Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coherent's (US) urology laser approved in Japan:

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health and Welfare has granted approval to Coherent (US) for use of the VersaPulse holmium laser to destroy urinary stones. The company says it is the first approval for this procedure in Japan using a solid-state laser. The product application was filed in May 1993 using data from clinical trials conducted at Kurume University Medical School and Nara Medical University. Japan is Coherent's largest potential market for holmium laser lithotripsy, according to Peter Falzon, manager of Coherent Japan. It is the world leader in high technology urinary stone management with over 500 extracorporeal shockwave lithotripter installations.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel